Cargando…

Effect of Liraglutide on Fat Mass Percentage Among Overweight and Obese Adults with Type 2 Diabetes: A Systematic Review

BACKGROUND: Obesity and type 2 diabetes mellitus (T2DM) are two global public health problems. Liraglutide, a glucagon-like peptide 1 analogue (GLP-1), is considered an effective option for weight loss. Hence, it is meaningful to understand the impact of GLP-1 therapy on body composition, particular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aladel, Alanoud, Aljaouni, Jamilah, Basaad, Reem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617533/ https://www.ncbi.nlm.nih.gov/pubmed/37915772 http://dx.doi.org/10.2147/DMSO.S417374

Ejemplares similares

Correlation of salivary immunoglobulin A with Body Mass Index and fat percentage in overweight/obese children
por: Perez, Mayra Manoella, et al.
Publicado: (2018)

The Role of Body Adiposity Index in Determining Body Fat Percentage in Colombian Adults with Overweight or Obesity
por: Ramírez-Vélez, Robinson, et al.
Publicado: (2017)

The Relationship Between Body Fat Percentage and Body Mass Index in Overweight and Obese Individuals in an Urban African Setting
por: Akindele, Mukadas O., et al.
Publicado: (2016)

Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review
por: Deng, You, et al.
Publicado: (2022)

Development of an Easy-to-Use Prediction Equation for Body Fat Percentage Based on BMI in Overweight and Obese Lebanese Adults
por: Itani, Leila, et al.
Publicado: (2020)

Body Fat Percentages by Dual-energy X-ray Absorptiometry Corresponding to Body Mass Index Cutoffs for Overweight and Obesity in Indian Children
por: Pandit, Deepa, et al.
Publicado: (2009)

Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes
por: Kim, Sun H., et al.
Publicado: (2013)

Liraglutide with Lifestyle Intervention in Adolescents with Overweight/Obesity, Nonalcoholic Fatty Liver Disease, and Type II Diabetes Mellitus
por: Kohut, Taisa, et al.
Publicado: (2021)

Degree of obesity and gastrointestinal adverse reactions influence the weight loss effect of liraglutide in overweight or obese patients with type 2 diabetes
por: Zhou, Fang, et al.
Publicado: (2023)

A simple equation to estimate body fat percentage in children with overweightness or obesity: a retrospective study
por: Cortés-Castell, Ernesto, et al.
Publicado: (2017)

Comparison of obesity and metabolic syndrome prevalence using fat mass index, body mass index and percentage body fat
por: Wong, Joseph C., et al.
Publicado: (2021)

Effects of liraglutide on gallbladder emptying: A randomized, placebo‐controlled trial in adults with overweight or obesity
por: Nexøe‐Larsen, Christina C., et al.
Publicado: (2018)

Myopenic Obesity Determined by Fat Mass Percentage Predicts Risk of Aspirin-Induced Bleeding in Chinese Older Adults
por: Wang, Xiting, et al.
Publicado: (2023)

Circulating Metabolites Associated with Body Fat and Lean Mass in Adults with Overweight/Obesity
por: Papandreou, Christopher, et al.
Publicado: (2021)

Body Mass Index and Percentage of Body Fat as Indicators for Obesity in an Adolescent Athletic Population
por: Etchison, William C., et al.
Publicado: (2011)

How to Estimate Fat Mass in Overweight and Obese Subjects
por: Donini, Lorenzo Maria, et al.
Publicado: (2013)

Trends of Underweight and Overweight/Obesity Among Japanese Schoolchildren From 2003 to 2012, Defined by Body Mass Index and Percentage Overweight Cutoffs
por: Shirasawa, Takako, et al.
Publicado: (2015)

OR14-2 Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial
por: Dandona, Paresh, et al.
Publicado: (2019)

Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series
por: Ishii, Satoshi, et al.
Publicado: (2019)

Performance of Body Fat Percentage, Fat Mass Index and Body Mass Index for Detecting Cardiometabolic Outcomes in Brazilian Adults
por: de Oliveira, Bianca Rodrigues, et al.
Publicado: (2023)

Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
por: Xie, Zeyu, et al.
Publicado: (2022)

Percentage Body Fat is As a Good Indicator for Determining Adolescents Who Are Overweight or Obese: A Cross-Sectional Study in Vietnam
por: Trang, Le Thu, et al.
Publicado: (2019)

Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis
por: Konwar, Mahanjit, et al.
Publicado: (2022)

Relationship between BMI with percentage body fat and obesity in Singaporean adults – The Yishun Study
por: Chen, Kexun Kenneth, et al.
Publicado: (2021)

Evaluation of miRNA-143 and miRNA-145 Expression and Their Association with Vitamin-D Status Among Obese and Non-Obese Type-2 Diabetic Patients
por: Aladel, Alanoud, et al.
Publicado: (2022)

Clinical Importance of FNDC-5 and Selectin-E mRNA Expression Among Type 2 Diabetics with and without Obesity
por: Verma, Amit K, et al.
Publicado: (2022)

Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study
por: Barnard-Kelly, Katharine, et al.
Publicado: (2022)

Use of Body Mass Index and Percentage Overweight Cutoffs to Screen Japanese Children and Adolescents for Obesity-Related Risk Factors
por: Okuda, Masayuki, et al.
Publicado: (2010)

Twenty-four-week effects of liraglutide on body composition, adherence to appetite, and lipid profile in overweight and obese patients with type 2 diabetes mellitus
por: Rondanelli, Mariangela, et al.
Publicado: (2016)

Racial/Ethnic Differences in the Percentage of Gestational Diabetes Mellitus Cases Attributable to Overweight and Obesity, Florida, 2004-2007
por: Kim, Shin Y., et al.
Publicado: (2012)

Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials
por: Davies, M. J., et al.
Publicado: (2017)

Association between the body mass index, waist circumference, and body fat percentage with erosive esophagitis in adults with obesity after sleeve gastrectomy
por: Zevallos-Ventura, Alba S., et al.
Publicado: (2022)

Effect of Weight Self-Stigma on Quality of Life and Dietary Habits among Adult Students in Riyadh, Saudi Arabia
por: Aladel, Alanoud, et al.
Publicado: (2023)

Time‐restricted eating and concurrent exercise training reduces fat mass and increases lean mass in overweight and obese adults
por: Kotarsky, Christopher J., et al.
Publicado: (2021)

Liraglutide in the management of type 2 diabetes
por: Wajcberg, Estela, et al.
Publicado: (2010)

The Role of BMI, Body Fat Mass and Visceral Fat in Executive Function in Individuals with Overweight and Obesity
por: Sánchez-SanSegundo, Miriam, et al.
Publicado: (2021)

Percentage of Body Fat Assessment Using Bioelectrical Impedance Analysis and Dual-Energy X-ray Absorptiometry in a Weight Loss Program for Obese or Overweight Chinese Adults
por: Li, Yi-Chun, et al.
Publicado: (2013)

Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China
por: Zhaohu, Hao, et al.
Publicado: (2022)

SAT-096 Later Timing of Energy Intake Associates with Higher Fat Mass in Adults with Overweight and Obesity
por: Zaman, Adnin, et al.
Publicado: (2019)

Lower Percentage of Fat Mass among Tai Chi Chuan Practitioners
por: Stagi, Silvia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lrs4785pki1g9f8b07ieoroorp